Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q4 2020?

34 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 91,091,040
Total 13F shares: 16,311,910
Share change: -886,018
Total reported value: $58,071,014
Put/Call ratio: 58%
Price per share: $3.56
Number of holders: 34
Value change: -$3,250,489
Number of buys: 11
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 221015100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	7.4%	6,767,584	$27,138,000	—	30 Sep 2020	13F
ADAMS STREET PARTNERS LLC	13F	Company	3.6%	3,275,616	$13,135,000	—	30 Sep 2020	13F
BVF INC/IL	13F	Company	1.9%	1,743,712	$6,992,000	—	30 Sep 2020	13F
Novo Holdings A/S	13F	Company	1.5%	1,389,498	$5,572,000	—	30 Sep 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.96%	875,000	$3,509,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	0.67%	606,114	$2,431,000	—	30 Sep 2020	13F
CHI Advisors LLC	13F	Company	0.64%	583,232	$2,339,000	—	30 Sep 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.48%	436,208	$1,749,000	—	30 Sep 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.42%	381,143	$1,528,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	0.18%	161,549	$647,000	—	30 Sep 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.17%	157,134	$630,000	—	30 Sep 2020	13F
Verition Fund Management LLC	13F	Company	0.16%	146,730	$588,000	—	30 Sep 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	133,700	$536,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	111,548	$447,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	103,558	$415,000	—	30 Sep 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.07%	61,724	$248,000	—	30 Sep 2020	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.06%	54,128	$217,000	—	30 Sep 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.05%	41,968	$168,000	—	30 Sep 2020	13F
Puissance Capital Management LP	13F	Company	0.04%	38,010	$152,000	—	30 Sep 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.04%	37,014	$148,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.04%	32,746	$131,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.03%	29,387	$118,000	—	30 Sep 2020	13F
Hikari Power Ltd	13F	Company	0.02%	19,959	$80,000	—	30 Sep 2020	13F
ALGERT GLOBAL LLC	13F	Company	0.01%	11,247	$45,000	—	30 Sep 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	6,450	$26,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	0%	4,303	$17,000	—	30 Sep 2020	13F
WHITTIER TRUST CO OF NEVADA INC	13F	Company	0%	4,200	$17,000	—	30 Sep 2020	13F
Cutler Group LLC / CA	13F	Company	0%	1,300	$5,000	—	30 Sep 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1,000	$4,000	—	30 Sep 2020	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	645	$3,000	—	30 Sep 2020	13F
Manchester Capital Management LLC	13F	Company	0%	215	$1,000	—	30 Sep 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	212	$1,000	—	30 Sep 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	4	$16	—	30 Sep 2020	13F

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q4 2020

As of 31 Dec 2020, Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,311,910 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, BVF INC/IL, Novo Holdings A/S, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, CHI Advisors LLC, DIMENSIONAL FUND ADVISORS LP, Telemetry Investments, L.L.C., and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.